Galmed Pharmaceuticals Ltd
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About GLMD
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.
Find out what a historical investment in Galmed Pharmaceuticals Ltd would be worth today using our GLMD stock calculator.
$7.50M
-
0.00%
92.14K
$1.07
$1.02
$1.06
$3.61
$0.74
Ready to start your investing journey with Stake?
Open an accountGLMD FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GLMD
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GLMD
on Stake
Buy GLMD from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of GLMD from only US$10 with fractional shares
